High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study

被引：22

作者：

Reyes, Henry D. ^{[1
]}

Miecznikowski, Jeffrey ^{[2
]}

Gonzalez-Bosquet, Jesus ^{[1
]}

Devor, Eric J. ^{[1
]}

Zhang, Yuping ^{[1
]}

Thiel, Kristina W. ^{[1
]}

Samuelson, Megan I. ^{[3
]}

McDonald, Megan ^{[1
]}

Stephan, Jean-Marie ^{[1
]}

Hanjani, Parviz ^{[4
]}

Guntupalli, Saketh ^{[5
]}

Tewari, Krishnansu S. ^{[6
]}

Backes, Floor ^{[7
]}

Ramirez, Nilsa ^{[8
]}

Fleming, Gini F. ^{[9
]}

Filiaci, Virginia ^{[10
]}

Birrer, Michael J. ^{[11
]}

Leslie, Kimberly K. ^{[1
]}

机构：

[1] Univ Iowa, Holden Comprehens Canc Ctr, Dept Obstet & Gynecol, Iowa City, IA 52242 USA

[2] SUNY Univ Buffalo, Dept Biostat, Buffalo, NY USA

[3] Univ Iowa, Holden Comprehens Canc Ctr, Dept Pathol, Iowa City, IA 52242 USA

[4] Abington Mem Hosp, Dept Gynecol Oncol, Hanjani Inst Gynecol Oncol, Abington, PA 19001 USA

[5] Univ Colorado Denver, Dept Obstet & Gynecol, Aurora, CO USA

[6] Univ Calif Irvine, Med Ctr, Div Gynecol Oncol, Orange, CA USA

[7] Ohio State Univ, Med Ctr, Dept Div Obstet & Gynecol, Columbus, OH 43210 USA

[8] Nationwide Childrens Hosp, Res Inst, Dept Pathol, Columbus, OH USA

[9] Univ Chicago, Sect Med Oncol, Chicago, IL 60637 USA

[10] Roswell Pk Canc Inst, NRG Oncol, Gynecol Oncol Grp, Biostat & Data Ctr, Buffalo, NY 14263 USA

[11] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA

来源：

GYNECOLOGIC ONCOLOGY | 2017年 / 146卷 / 02期

关键词：

PHASE-III TRIAL; OVEREXPRESSION; CARCINOMA; CHEMOTHERAPY; PROGNOSIS; PROLIFERATION; METASTASIS; MIGRATION; SUGGESTS; TUMORS;

D O I：

10.1016/j.ygyno.2017.05.017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objective. Gynecologic Oncology Group (GOG) 177 demonstrated that addition of paclitaxel to a backbone of adriamycin/cisplatin improves overall survival (OS) and progression-free survival (PFS) for patients with advanced or recurrent endometrial cancer. Using patient specimens from GOG-177, our objective was to identify potential mechanisms underlying the improved clinical response to taxanes. Stathmin (STMN1) is a recognized poor prognostic marker in endometrial cancer that functions as a microtubule depolymerizing protein, allowing

引用

页码：247 / 253

页数：7

共 50 条

[21] Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
Bishop, Erin A.
Java, James J.
Moore, Kathleen N.
Spirtos, Nick M.
Pearl, Michael L.
Zivanovic, Oliver
Kushner, David M.
Backes, Floor
Hamilton, Chad A.
Geller, Melissa A.
Hurteau, Jean
Mathews, Cara
Wenham, Robert M.
Ramirez, Pedro T.
Zweizig, Susan
Walker, Joan L.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : 109.e1 - 109.e11
[22] Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study
Secord, Angeles Alvarez
Lee, Paula S.
Darcy, Kathleen M.
Havrilesky, Laura J.
Grace, Lisa A.
Marks, Jeffrey R.
Berchuck, Andrew
GYNECOLOGIC ONCOLOGY, 2006, 101 (03) : 390 - 397
[23] Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
Singh, Meenakshi
Zaino, Richard J.
Filiaci, Virginia J.
Leslie, Kimberly K.
GYNECOLOGIC ONCOLOGY, 2007, 106 (02) : 325 - 333
[24] Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group
Miller, David Scott
Randall, Marcus E.
Filiaci, Virginia
GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 312 - 322
[25] Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol
Creasman, William T.
Ali, Shamshad
Mutch, David G.
Zaino, Richard J.
Powell, Matthew A.
Mannel, Robert S.
Backes, Floor J.
DiSilvestro, Paul A.
Argenta, Peter A.
Pearl, Michael L.
Lele, Shashikant B.
Guntupalli, Saketh R.
Waggoner, Steven
Spirtos, Nick
Boggess, John F.
Edwards, Robert P.
Filiaci, Virginia L.
Miller, David S.
GYNECOLOGIC ONCOLOGY, 2017, 145 (03) : 519 - 525
[26] Outcome of ovarian preservation during surgical treatment for endometrial cancer: A Taiwanese Gynecologic Oncology Group study
Lau, Hei-Yu
Chen, Min-Yu
Ke, Yu-Min
Chen, Jen-Ruei
Chen, I-Hui
Liou, Wen-Shiung
Fu, Hung-Chun
Chang, Cheng-Chang
Hsu, Keng-Fu
Wang, Kung-Liahng
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2015, 54 (05): : 532 - 536
[27] An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosis
Segev, Yakir
Gemer, Ofer
Helpman, Limor
Hag-Yahia, Nasreen
Eitan, Ram
Raban, Oded
Vaknin, Zvi
Ben-Arie, Alon
Amit, Amnon
Levy, Tally
Namazov, Ahmet
Voldarsky, Michael
Ben Shachar, Inbar
Atlas, Ilan
Bruchim, Ilan
Lavie, Ofer
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 148 (01) : 79 - 86
[28] Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study
DuPont, Nefertiti C.
Enserro, Danielle
Brady, Mark F.
Moxley, Katherine
Walker, Joan L.
Cosgrove, Casey
Bixel, Kristin
Tewari, Krishnansu S.
Thaker, Premal
Hendrickson, Andrea E. Wahner
Rubin, Stephen
Fujiwara, Keiichi
Casey, A. Catherine
Soper, John
Burger, Robert A.
Monk, Bradley J.
GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 398 - 405
[29] Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study
Bartels, Peter H.
Garcia, Francisco A. R.
Trimble, Cornelia L.
Kauderer, James
Curtin, John
Lim, Peter C.
Hess, Lisa M.
Silverberg, Steven
Zaino, Richard J.
Yozwiak, Michael
Bartels, Hubert G.
Alberts, David S.
GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 129 - 135
[30] Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study
Hibler, Elizabeth A.
Kauderer, James
Greene, Mark H.
Rodriguez, Gustavo C.
Alberts, David S.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (11): : 1228 - 1232

← 1 2 3 4 5 →